Effects of BM 13.177, a new antiplatelet drug in patients with atheroscleortic disease
- 1 August 1984
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 35 (4) , 371-378
- https://doi.org/10.1016/0049-3848(84)90229-9
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Investigations on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human plateletsThrombosis Research, 1984
- Role of blood platelets and prostaglandins in coronary artery diseaseThe American Journal of Cardiology, 1981
- UK-37,248, A novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activityThrombosis Research, 1981
- Platelet function studies in coronary heart disease: VIII. Decreased platelet sensitivity to prostacyclin in patients with myocardial ischaemiaThrombosis Research, 1980
- The Pathogenesis of AtherosclerosisNew England Journal of Medicine, 1976
- The Pathogenesis of AtherosclerosisNew England Journal of Medicine, 1976
- Studies on the Liberation of β‐Thromboglobulin from Human Platelets in VitroBritish Journal of Haematology, 1976
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962